Sophie Hordijk on A New Cause of the Hereditary Bleeding Disorder of VWD Type 1
Zeldzame bloedstollingsstoornissen shared on LinkedIn:
”New insights into Von Willebrand disease thanks to research
The latest issue of the Dutch Journal of Hematology features an interview with Sophie Hordijk, PhD candidate at the Department of Hematology at Erasmus MC in Ruben Bierings’ research group.
Sophie recently published a study in the leading journal Blood, in which she and her colleagues identified a new cause of the hereditary bleeding disorder Von Willebrand disease type 1.
The study points to impaired secretion of Von Willebrand Factor by endothelial cells as a possible key to a better understanding of the condition.
Curious about the scientific article?
Read it here.
Want to know more about Sophie Hordijk, Ruben Bierings, and the NTvH journal?
Take a look on LinkedIn:
- Sophie Hordijk
- Ruben Bierings
- Nederlands Tijdschrift voor Hematologie (Dutch Journal of Hematology)
Read the full interview here.”
Read the full article in Blood.
Article: A novel cause of type 1 von Willebrand disease: impaired exocytosis of Weibel-Palade bodies due to biallelic MADD variants
Authors: Sophie Hordijk, Stijn A. Groten, Petra E. Bürgisser, Sebastiaan N. J. Laan, Georg Christoph Korenke, Tomáš Honzík, Diane Beysen, Frank W. G. Leebeek, Paul A. Skehel, Maartje van den Biggelaar, Tom Carter, Ruben Bierings
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 7, 2026, 08:50Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
-
Jan 7, 2026, 06:41Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
-
Jan 7, 2026, 05:47Michael Makris: The Wakley Prize Essay Published in Today’s Lancet is an Excellent Read
-
Jan 7, 2026, 05:36Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
-
Jan 7, 2026, 05:15Glaivy Batsuli Reflects on ASH25
-
Jan 7, 2026, 05:04Heghine Khachatryan on VWD: A Landmark in the History of Hematology
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications